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Abstract
Background: Obesity has been linked with shorter telomere length, both of which have been implicated in ageing, but the impact of early life 
adiposity on telomere length is unclear.
Methods: We included 2,479 participants from the MRC National Survey of Health and Development with measurements of body mass 
index, waist and hip circumference, and leukocyte telomere length (LTL) at age 53, of whom 1,000 had second measurements at ages 60–64. 
Relative LTL was measured with rt-PCR. Linear regression was performed to investigate associations between adiposity and LTL. Body mass 
index from childhood through adulthood was used to assess adiposity across the life course.
Results: We found no cross-sectional associations between adiposity measures and LTL at ages 53 or 60–64. Longitudinally, each unit gain 
in waist circumference weakly corresponded with a 0.06% (95% CI: −1.31 to 0.10) LTL decrease annually, with association approaching 
statistical significance (p = 0.09). Being overweight at ages 6 and 15 corresponded to a nonsignificant shorter LTL at age 53 and they were 
associated with 2.06% (95% CI: 0.05–4.08%) and 4.26% (1.98–6.54%) less LTL attrition in midlife, respectively, compared to those who 
were not overweight.
Conclusion: There is a weak indication that greater telomere loss was seen with greater concurrent body mass index gain. Adolescent 
overweight corresponded to shorter telomeres in midlife, albeit weakly, and with less subsequent attrition. Our findings point toward potential 
pathways which may link adiposity and ageing outcomes.
Keywords: Obesity—Life course—Telomere length—Overweight—Cohort
Overweight and obesity, indicated by high body mass index (BMI), 
accounted for 4% of global disability-adjusted life years (DALYs) in 
2010 (1). There is an evidence that early-life obesity and its changes 
through adulthood are associated with indicators of healthy ageing 
in later life such as cardiovascular (2,3) and cognitive functions (4), 
but its underlying mechanism remains unclear.
Telomeres are DNA–protein complexes at the ends of chromo-
some which maintain chromosomal stability (5). Telomere shortens 
as an individual ages and therefore telomere attrition is considered 
a hallmark of ageing (6). There is evidence that shorter telomeres 
are linked with increased risk of death, as reported in a recent meta-
analysis of two cohorts in America and Europe which included 
adults aged 43–75 (7). It is also suggested that telomere shorten-
ing is involved in the development of age-related diseases including 
cardiovascular disease and cancer (8), both of which are linked with 
obesity. A cross-sectional association between high BMI or obesity 
and shorter telomere length has been reported (9). However, a recent 
meta-analysis including over 8,000 individuals showed no differ-
ence in telomere length between obese individuals and those with 
normal weight (10); nevertheless, high heterogeneity was reported 
(I2  = 99%). Apart from variability arising from different assay or 
DNA extraction methods (11), within-person variability in this asso-
ciation may need to be teased out since most studies included only 
had a single measurement of BMI and telomere length (10). Among 
the few studies investigating repeated measurements of adiposity 
and telomere length in adult life, conflicting results have been shown 
(12–15). Little is known regarding the impact of adiposity changes 
over the life course on telomere length in later life.
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We investigated the association between adiposity dynam-
ics and leukocyte telomere length (LTL) measured at ages 53 and 
60–64 years among participants of the Medical Research Council 
(MRC) National Survey of Health and Development (NSHD, also 
known as the 1946 British Birth Cohort). We evaluated whether 
change in BMI, waist, or hip circumference was associated with con-
current LTL change between ages 53 and 60–64 years. Furthermore, 
the repeated recordings of BMI obtained over the life course of 
NSHD participants allowed investigations of overweight from age 2 
onwards in relation to telomere length and telomere attrition.
Methods
Study Population
The MRC NSHD has been described in detail elsewhere. This 
cohort is based on a nationally representative sample of 5,362 
births out of all the single births to married mothers that occurred 
in 1 week in March 1946 in England, Scotland, and Wales. The 
cohort has been followed up 24 times and the present study used 
data collected up to 60–64  years when telomere length was last 
measured (16). At age 60–64, study members still alive and with a 
known current address in England, Scotland, or Wales were invited 
for an assessment at one of six clinical research facilities (CRF) 
or to be visited by a research nurse at home. Invitations were not 
sent to those who had died (N  =  778), who were living abroad 
(N = 570), had previously withdrawn from the study (N = 594), or 
had been lost to follow-up (N = 564). Of the 2,856 invited partici-
pants, 2,229 (78%) were assessed: 1,690 (59%) attended a CRF 
and the remaining 539 were visited at home. The participating 
sample remains broadly representative of native born British men 
and women of the same age.
Ethical approval was obtained from the Greater Manchester 
Local Research Ethics Committee and the Scotland Research Ethics 
Committee. Written informed consent was obtained from the study 
member for each component of each data collection.
Adiposity Assessment in Midlife
Weight (kg), height (m), waist, and hip circumferences (cm) were 
measured by trained nurses in a standardized manner at ages 53 and 
60–64 years. BMI (kg/m2) was calculated from weight and height. 
We divided BMI into four categories (<18.5, 18.5–25, 25–30, and 
≥30 kg/m2) according to the National Health Institute (NIH) guide-
lines and dichotomously into nonoverweight and overweight using 
25 kg/m2 as a cut-off point. Abdominal obesity was defined as waist 
circumference >102 cm for men and >88 cm for women. We calcu-
lated annual changes in each adiposity measure between ages 53 and 
60–64 using the interval between the two measurements.
BMI at Earlier Ages
Body mass index during childhood through adulthood was calcu-
lated from measured height and weight at ages 2, 4, 6, 7, 11, 15, 36, 
and 43, and from self-reported height and weight at ages 20 and 26. 
Prior to age 20, overweight status was dichotomized using cut-offs 
derived from centile curves corresponding to BMI of 25 kg/m2 at age 
18 in six nationally representative surveys (17).
Telomere Length Measurement
DNA was extracted from frozen EDTA blood samples using 
Puregene DNA isolation kits (Flowgen, Leicestershire, UK) (18). 
Leukocyte telomere length was measured as a ratio (T/S ratio) to 
standard reference DNA in the same laboratory according to a 
previously validated real-time polymerase chain reaction (rt-PCR) 
technique in a blinded fashion (19). Measurements were performed 
in quadruplicate on an Applied Biosystems 7900HT Fast Real 
Time PCR system with 384-well plate capacity. The intra-assay 
coefficient of variation was 2.7% while the inter-assay coefficient 
of variation was 5.1%. Four internal control DNA samples of 
known telomere length were used to normalize assays in differ-
ent runs. LTL measurements were available in 2,479 individuals 
at 53 years and 1,004 individuals at 60–64 years. For participants 
with two repeated measurements, we calculated telomere attri-
tion as the annual percentage change in LTL (ΔLTL) as follows: 
[(LTL60–64 – LTL53) × 100/ LTL53)]/interval (years) between the two 
measurements.
Covariates
We used prospective information on socioeconomic position as a 
potential confounder since it is known to be associated with BMI 
and with LTL (20). Childhood and adult socioeconomic position 
(SEP) were based on father’s occupation at age 4 and own occu-
pational class at age 53  years. To categorize SEP, the Registrar 
General’s classification was used to dichotomize individuals into 
nonmanual and manual workers. Wherever possible, missing values 
were imputed from adjacent ages (33 values from age 11 and 14 
values from age 15 for childhood SEP; 107 values from age 36; 
and 107 values from age 43 for adult SEP).  Diagnosis of diabetes, 
coronary heart disease and cancer were self-reported at ages 53 and 
60–64.
Statistical Analysis
Regression models were used to investigate associations of continu-
ous and categorical BMI and overweight status with LTL at ages 53 
(N = 2,479) and 60–64 (N = 1,004) years. LTL and T/S ratio were 
not normally distributed and was logarithmically transformed and 
multiplied by 100 (21). Models were subsequently adjusted for sex 
and for childhood and adult SEP, and then additionally for history 
of diabetes, coronary heart disease, and cancer. All analyses were 
repeated replacing BMI by waist and then hip circumference. As 
some participants had extreme values of LTL, we performed a sensi-
tivity analysis by excluding LTL values below the 5th percentile and 
above 95th percentile.
Regression models were then used to investigate the association 
of annual changes in LTL (%) with annual changes in BMI, waist 
circumference, or hip circumference among those with two repeated 
measurements (N = 1,000). Since weight change explains the major-
ity of change in adult BMI, we also performed a similar analysis 
using weight instead of BMI. Analyses were conditioned on sex, 
and childhood and adult SEP, and then additionally adjusted for the 
baseline adiposity measures at age 53.
To investigate any impact of BMI at earlier ages, regression 
models were fitted with LTL at age 53 and annual change in LTL 
between ages 53 and 60–64 as outcomes including using BMI at 
ages 2, 4, 6, 7, 11, 15, 20, 26, 36, and 43 years separately. Models 
were adjusted for sex, childhood SEP, adult SEP, and BMI at age 
53. Analyses were repeated using past BMI-based overweight 
status.
All analyses were performed with STATA version 14 (STATA 
Corp., College Station, TX).
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Results
A total of 2,479 participants had available information on BMI and 
LTL at age 53, 1,004 had both measurements at age 60–64 and 1,000 at 
both ages. Characteristics of study participants are presented in Table 1. 
The mean interval [± standard deviation (SD)] between measurements 
for the subgroup with two measurements was 10.1 ± 1.1 years. Shorter 
LTL at age 53 was correlated with LTL shortening between age 53 and 
60–64.
Cross-Sectional Associations Between Adiposity 
and Telomere Length at Ages 53 and 60–64
No cross-sectional associations were seen between BMI, waist cir-
cumference or hip circumference and LTL at ages 53 or 60–64 
(Table 2, unadjusted models). Similarly, there were no associations 
when categories of BMI or abdominal obesity were used (Table 2). 
Associations between adiposity measures, overweight status, and 
LTL were similar to the unadjusted models after adjustment for sex, 
Table 1. Characteristics of Study Participants at Age 53 and 60–64 Years with LTL Measurements
At 53 Y (N = 2,479) At 60–64 Y (N = 1,004)
Men Women Men Women
Manual adult socioeconomic status, N (%) 484 (38.88) 358 (29.01) 146 (30.74) 130 (24.57)
Manual childhood socioeconomic status, N (%) 703 (56.47) 706 (57.21) 257 (54.11) 287 (54.25)
Cancer, N (%) 30 (2.41) 76 (6.16) 31 (6.53) 66 (12.48)
Diabetes, N (%) 35 (2.81) 35 (2.84) 34 (7.11) 26 (4.91)
Chronic heart disease, N (%) 61 (4.90) 31 (2.51) 45 (9.76) 13 (2.51)
BMI (kg/m2) 27.39 (3.90) 27.33 (5.31) 27.69 (4.01) 28.05 (5.27)
Waist circumference (cm) 97.67 (10.45) 85.52 (12.49) 100.37 (10.69) 92.44 (12.92)
Hip circumference (cm) 104.20 (6.85) 108.10 (10.53) 104.17 (7.29) 107.00 (10.81)
LTL (T/S ratio) 1.64 (0.93) 1.45 (0.90) 1.09 (0.40) 1.15 (0.40)
Note: Data are presented in mean (SE), unless otherwise indicated. LTL = leukocyte telomere length.
Table 2. Associations Between BMI, Overweight, and LTL at Ages 53 and 60–64
Unadjusted Model Multivariable 1* Multivariable 2†
N (%)
Percent  
Difference 95% CI
Percent  
Difference 95% CI
Percent  
Difference 95% CI
At 53 years
BMI, kg/m2
 Continuous 0.03 −0.51 to 0.45 −0.04 −0.51 to 0.44 −0.07 −0.55 to 0.41
 <18.5 6 (0.24) −2.96 −48.72 to 42.80 −4.19 −49.54 to 41.17 −4.37 −49.75 to 41.00
 18.5–25 803 (32.39) Reference Reference Reference
 25–30 1,087 (43.85) 0.48 −4.71 to 5.68 −1.89 −7.08 to 3.30 −2.11 −7.34 to 3.11
 ≥30 583 (23.52) 2.09 −3.98 to 8.16 1.22 −4.80 to 7.24 0.85 −5.24 to 6.94
Nonoverweight 809 (32.63) Reference Reference Reference
 Overweight or obese 1,670 (67.37) 1.07 −3.71 to 5.85 −0.74 −5.52 to 4.02 −1.04 −5.86 to 3.78
 Waist circumference (cm) 0.27 0.09 to 0.44 −0.0007 −0.20 to 0.19 −0.02 −0.28 to 0.18
 Hip circumference (cm) −0.07 −0.33 to 0.17 0.004 −0.24 to 0.26 −0.002 −0.25 to 0.25
Nonabdominally obese 1,652 (66.64) Reference Reference Reference
 Abdominally obese 827 (33.36) 0.64 −4.12 to 5.39 1.13 −3.60 to 5.87 1.11 −3.60 to 5.87
At 60–64 years
BMI, kg/m2
 Continuous −0.07 −0.53 to 0.38 −0.10 −0.55 to 0.35 −0.11 −0.57 to 0.35
 <18.5 4 (0.40) 9.83 −24.22 to 43.89 10.09 −23.8 to 44.04 9.07 −2.50 to 43.14
 18.5–25 298 (29.68) Reference Reference Reference
 25–30 419 (41.73) −2.24 −7.37 to 2.87 −1.89 −7.00 to 3.22 −1.97 −7.11 to 3.18
 ≥30 283 (28.19) −1.56 −7.17 to 4.05 −1.72 −7.31 to 3.88 −1.84 −7.53 to 3.84
Nonoverweight 302 (30.08) Reference Reference Reference
 Overweight or obese 702 (69.92) −2.10 −6.75 to 2.55 −1.95 −6.59 to 2.68 −2.05 −6.74 to 2.64
 Waist circumference (cm) −0.11 −0.28 to 0.06 −0.04 −0.22 to 0.14 −0.004 −0.22 to 0.14
 Hip circumference (cm) 0.02 −2.01 to 0.24 −0.03 −0.26 to 0.20 −0.03 −0.27 to 0.19
Nonabdominally obese 493 (49.10) Reference Reference Reference
 Abdominally obese 511 (50.90) 2.25 −2.01 to 6.52 1.19 −3.17 to 5.55 1.19 −3.17 to 5.55
Note: BMI = body mass index; LTL = leukocyte telomere length.
*Adjusted for sex.
†Additional adjustment for childhood SEP and adult SEP.
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and childhood and adult SEP (Table  2), although a weak inverse 
trend between adiposity and LTL was indicated. Adjustment for his-
tory of diabetes, coronary heart disease, and cancer or excluding 
extreme LTL values did not alter any of these null findings (results 
not shown).
Longitudinal Associations Between Adiposity and 
Telomere Length
Overall, there is an indication toward inverse associations between 
change in adiposity and telomere length (Table  3). An annual 
increase of one unit waist circumference between 53 and 60–64 was 
associated with a −0.60% greater annual decrease in LTL (95% CI: 
−1.31 to 0.10) which approached statistical significance (p =  .09). 
This association was slightly weaker when adjusted for baseline 
waist circumference. Longitudinal associations between changes in 
BMI, weight or hip circumference and LTL were similar but weaker 
(Table 3).
Associations Between BMI and Overweight in 
Earlier Life and Telomere Length
Higher earlier BMI and overweight status were generally weakly 
associated with shorter LTL at age 53, but slightly longer LTL at 
60–64 (Table 4). Higher BMI and overweight at previous ages there-
fore tended to be associated with less LTL attrition between ages 53 
and 60–64 (Figure 1), most strongly for BMI and overweight at age 
15 (eg, 0.39%, 95% CI: 0.12–0.67% annual change in LTL for each 
unit BMI increase at age 15).
Discussion
We observed a weak inverse association between gain in adiposity 
and telomere attrition over the same time period. There was evidence 
of associations of earlier life BMI and LTL attrition, with higher BMI 
and overweight at 15 years being associated with less LTL attrition 
in midlife.
Common biological pathways linking obesity and ageing out-
comes have been identified, which support our findings on concur-
rent BMI gain and telomere attrition in midlife. Increasing adiposity 
may induce oxidative stress (22), which have been linked to reduced 
activity of telomerase (23), the enzyme responsible for telomere 
maintenance. In addition to affecting telomerase pathways, adipose 
tissue in obese animal models shows signs of accumulating DNA 
damage and cellular ageing such as higher levels of p53 protein (24). 
An indirect role of obesity may also occur via circulating glucose 
and lipids, commonly elevated in overweight or obese individu-
als. High circulating glucose increases the generation of advanced 
glycated end products (25), and high lipid levels may induce lipid 
peroxidation (26), both of which contribute to oxidative stress and 
inflammation. Additionally, hyperinsulinemia which often accompa-
nies obesity stimulates the mechanistic target of rapamycin (mTOR), 
whose blockade results in prolonged lifespan in mice (27). A recent 
study suggested a beneficial effect of mTOR by mediating the anti-
obesity effects of fibroblast growth factor 21 (FGF21) (28), implying 
complex pathways linking obesity and ageing which may involve 
negative feedback mechanisms.
We did not find cross-sectional associations between BMI or 
overweight status and telomere length in midlife, which is similar to 
a lack of association observed in a meta-analysis (10). Nevertheless, 
point estimates at both ages 53 and 60–64 suggested a weak inverse 
trend in the fully adjusted models, corroborating shorter telomeres 
with higher adiposity that we recently reported in American popu-
lations (29). Longitudinally, the weak association between greater 
adiposity gain and greater telomere attrition in midlife supports the 
inverse correlation between 5-year changes in adiposity and telo-
mere length in the PREDIMED-NAVARRA trial (12). With respect 
to waist circumference, each SD change within a 6-year observation 
was reported to longitudinally correspond to 41.84 base pair LTL 
decrease (SE: 16.39 base pair) in a study including 2,981 Dutch indi-
viduals aged 18–65 (30). On the other hand, a Danish study including 
over 4,500 adult Caucasians showed a lack of association between 
weight change and telomere attrition (31). This may indicate that 
weight change correlates to a different extent with telomere length 
than fat distribution. Although variation in telomere assays has been 
reported to hamper comparability (32,33), all aforementioned stud-
ies used rt-PCR to assess relative telomere length, suggesting add-
itional factors, such as age- and cohort-specific characteristics, to 
contribute to this discrepancy.
Our findings suggested that there was little consistent asso-
ciation between early life BMI and LTL in midlife. Positive asso-
ciations were seen between early life adiposity, particularly at age 
15, and LTL change between ages 53 and 60–64. With regards to 
LTL at younger ages, a study based on the Northern Finland Birth 
Cohort 1966 observed a positive association between BMI meas-
ured at childhood adiposity rebound (age ~5  years) with LTL at 
age 31 in women (34). Also in the same study, less telomere attri-
tion between ages 60 and 70 was seen with greater gain in BMI 
between ages 12 and 24 months (34). A German cohort of 1,000 
adults aged 50–75 also saw nonsignificant trends suggesting less 
8-year telomere attrition with longer duration of overweight since 
age 20. Together, these findings point towards a possible benefit of 
having larger body size earlier in life on telomere length in mid- to 
late adulthood. We speculate that this phenomenon may support 
the “thrifty telomere” hypothesis (35), which proposes that telo-
mere length acts as a marker of one’s limited resources over the life 
course, known as “disposable soma” (36). This theory suggests hav-
ing shorter telomeres to start with results in a more thrifty invest-
ment in maintenance efforts and reduced cell proliferation (35). 
Since telomere shortens with each cell replication (5), this eventually 
leads to decreased telomere attrition. Such a mechanism is suggested 
to explain less telomere attrition with shorter LTL at baseline as 
seen in our study and others (37,38).
Table  3. Associations Between Changes in BMI and Telomere 
Attrition
ΔLTL*
Percent  
Difference 95% CI
Annual BMI change, kg/m2 −1.01 −3.14 to 1.13
 Adjusted for baseline BMI −0.93 −3.09 to 1.24
Annual weight change, kg −0.25 −1.02 to 0.52
 Adjusted for baseline weight −0.26 −1.04 to 0.51
Annual waist circumference change, cm −0.60 −1.31 to 0.10
 Adjusted for baseline waist circumference −0.59 −1.32 to 0.14
Annual hip circumference change, cm −0.65 −1.57 to 0.26
 Adjusted for baseline hip circumference −0.69 −1.63 to 0.26
Note: All models were Adjusted for sex, childhood SEP, and adulthood SEP. 
Baseline measurements refer to measurements at age 53 years. BMI = body 
mass index; LTL = leukocyte telomere length.
*Annual percentage change in LTL.
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The strength on this study lies in the repeated measurements of 
BMI since childhood through adulthood, and two repeated assess-
ments of adiposity and LTL at the same ages in midlife which 
allowed a longitudinal analysis. We used a measure of relative telo-
mere length which showed better comparability across laboratories 
than absolute measures of telomere length (33). A limitation of this 
study is that misclassification may have occurred when classifying 
individuals based on BMI, waist, and hip circumference since they 
do not directly reflect body composition. However, BMI and waist 
circumference has been shown to be equally relevant for cardiovas-
cular risk factors in comparison with fat mass (39). Individuals who 
had higher BMI were at higher risk of cardiovascular disease and 
may die prior to LTL assessment at age 53, and this may result in 
underestimation of the observed associations.
In summary, we found little evidence on longitudinal associ-
ation between adiposity and telomere length and attrition in mid-
life. Additionally, we found a positive association between early life 
overweight and telomere attrition in midlife which may support the 
“thrifty telomere” hypothesis and indicate that being overweight 
in early life could alter telomere maintenance in later life. Further 
investigations are needed to assess whether telomere attrition lies 
in the pathways between early life adiposity and ageing-related 
outcomes.
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